80 related articles for article (PubMed ID: 25647613)
1. LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET.
Mezquita B; Pineda E; Mezquita J; Mezquita P; Pau M; Codony-Servat J; Martínez-Balibrea E; Mora C; Maurel J; Mezquita C
Mol Carcinog; 2016 May; 55(5):411-9. PubMed ID: 25647613
[TBL] [Abstract][Full Text] [Related]
2. Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells.
Kim SJ; Seo JH; Lee YJ; Yoon JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Oncology; 2005; 68(2-3):204-11. PubMed ID: 16015035
[TBL] [Abstract][Full Text] [Related]
3. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
Hua H; Chen W; Shen L; Sheng Q; Teng L
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
[TBL] [Abstract][Full Text] [Related]
5. Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells.
Fan F; Gray MJ; Dallas NA; Yang AD; Van Buren G; Camp ER; Ellis LM
Mol Cancer Ther; 2008 Sep; 7(9):3064-70. PubMed ID: 18790786
[TBL] [Abstract][Full Text] [Related]
6. GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction.
Huang SM; Chen TS; Chiu CM; Chang LK; Liao KF; Tan HM; Yeh WL; Chang GR; Wang MY; Lu DY
Endocr Relat Cancer; 2014 Feb; 21(1):73-84. PubMed ID: 24165321
[TBL] [Abstract][Full Text] [Related]
7. Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.
Jayasinghe C; Simiantonaki N; Kirkpatrick CJ
BMC Cancer; 2015 Mar; 15():104. PubMed ID: 25880726
[TBL] [Abstract][Full Text] [Related]
8. Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.
Troiani T; Martinelli E; Napolitano S; Vitagliano D; Ciuffreda LP; Costantino S; Morgillo F; Capasso A; Sforza V; Nappi A; De Palma R; D'Aiuto E; Berrino L; Bianco R; Ciardiello F
Clin Cancer Res; 2013 Dec; 19(24):6751-65. PubMed ID: 24122793
[TBL] [Abstract][Full Text] [Related]
9. VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1/cMet in colon cancer cells.
Tomida C; Yamagishi N; Nagano H; Uchida T; Ohno A; Hirasaka K; Nikawa T; Teshima-Kondo S
Int J Oncol; 2018 Apr; 52(4):1350-1362. PubMed ID: 29532881
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death.
Ametller E; García-Recio S; Pastor-Arroyo EM; Callejo G; Carbó N; Gascón P; Almendro V
Cancer Biol Ther; 2011 Jan; 11(1):4-13. PubMed ID: 20980803
[TBL] [Abstract][Full Text] [Related]
11. Aberrant, ectopic expression of VEGF and VEGF receptors 1 and 2 in malignant colonic epithelial cells. Implications for these cells growth via an autocrine mechanism.
Ahluwalia A; Jones MK; Szabo S; Tarnawski AS
Biochem Biophys Res Commun; 2013 Aug; 437(4):515-20. PubMed ID: 23831629
[TBL] [Abstract][Full Text] [Related]
12. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N
Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204
[TBL] [Abstract][Full Text] [Related]
13. The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation.
Kim JY; Hwang JH; Zhou W; Shin J; Noh SM; Song IS; Kim JY; Lee SH; Kim J
Epigenetics; 2009 Jul; 4(5):313-21. PubMed ID: 19633424
[TBL] [Abstract][Full Text] [Related]
14. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.
Meng RD; Shelton CC; Li YM; Qin LX; Notterman D; Paty PB; Schwartz GK
Cancer Res; 2009 Jan; 69(2):573-82. PubMed ID: 19147571
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
Kawahara S; Otsuji Y; Nakamura M; Murakami M; Murate T; Matsunaga T; Kanoh H; Seishima M; Banno Y; Hara A
Anticancer Drugs; 2013 Jun; 24(5):473-83. PubMed ID: 23426175
[TBL] [Abstract][Full Text] [Related]
16. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4.
Broggini M; Marchini SV; Galliera E; Borsotti P; Taraboletti G; Erba E; Sironi M; Jimeno J; Faircloth GT; Giavazzi R; D'Incalci M
Leukemia; 2003 Jan; 17(1):52-9. PubMed ID: 12529660
[TBL] [Abstract][Full Text] [Related]
17. Periostin induces chemoresistance in colon cancer cells through activation of the PI3K/Akt/survivin pathway.
Xiao ZM; Wang XY; Wang AM
Biotechnol Appl Biochem; 2015; 62(3):401-6. PubMed ID: 24372557
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro.
Schönau KK; Steger GG; Mader RM
Cancer Lett; 2007 Nov; 257(1):73-8. PubMed ID: 17686575
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation status of VEGF receptor genes: a possible epigenetic biomarker to anticipate the efficacy of intracellular-acting VEGF-targeted drugs in cancer cells.
Kim J; Hwang J; Jeong H; Song HJ; Shin J; Hur G; Park YW; Lee SH; Kim J
Epigenetics; 2012 Feb; 7(2):191-200. PubMed ID: 22395469
[TBL] [Abstract][Full Text] [Related]
20. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
